SL Science Holding Limited
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsSL Science Holding Limited is a Cayman Islands-incorporated Nasdaq-listed company that became the public parent of SL BIO Ltd. through a June 12, 2026 business combination.
What they do
SL Science Holding Limited completed a business combination on June 12, 2026, in which HSPT and SL BIO Ltd. became its wholly-owned subsidiaries. The company trades on the Nasdaq Stock Market under the ticker SLBT and is organized under the laws of the Cayman Islands, with principal executive offices in Taipei, Taiwan. As of June 18, 2026, it had 560,759,757 ordinary shares outstanding.
Revenue drivers
- No disclosed operating segments — The filing excerpt does not identify any revenue-generating segments or products for SLBT; the company’s business description in Item 4 was not provided beyond corporate and transaction details.
Recent performance
The provided XBRL data show total assets of $11,784, total liabilities of $27,454, and shareholder equity of negative $15,670 as of December 31, 2025. Cash and equivalents were reported as $0.00 as of March 17, 2025. No revenue, net income, or operating cash flow figures are included in the available excerpts. These figures are pre-business-combination and reflect a shell-like balance sheet with liabilities exceeding assets.
Strategy
The company completed a business combination on June 12, 2026, bringing together HSPT and SL BIO Ltd. under a new public holding company, SL Science Holding Limited. It trades on Nasdaq under the symbol SLBT. The transaction involved a PIPE Financing with subscription agreements signed with certain investors. No further strategy statements or operating plans are included in the provided excerpt.
Risks
- Shell company history — The filing checks the box indicating the registrant is not a shell company as of the annual report, but the company operated as a blank-check entity prior to the June 2026 business combination.
- Negative shareholder equity — As of December 31, 2025, total liabilities of $27,454 exceeded total assets of $11,784, producing shareholder equity of negative $15,670.
- No cash on hand — The XBRL data show cash and equivalents of $0.00 as of March 17, 2025, indicating no liquidity at that date.
- Limited operating history — The provided excerpt does not include a business description, revenue-generating operations, or historical financial statements beyond the specified balance sheet items.
Outlook
No management outlook, guidance, or forward-looking operating targets are included in the provided excerpt. The company completed its business combination on June 12, 2026, and had 560,759,757 ordinary shares outstanding as of June 18, 2026.